Nautilus Biotechnology (NAUT) Beats Q2 Earnings Estimates by $0.03
Earnings Results Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly earnings results on July 28, 2026 that exceeded analyst expectations. The Healthcare company reported…
Read more
